Preliminary findings with regard to risk factors in the development of tardive dyskinesia
Kane, J.; Struve, F.; Woerner, M.; Weinhold, P.
Psychopharmacology Bulletin 17(1): 47-49
1981
ISSN/ISBN: 0048-5764 PMID: 6112775 Document Number: 182508
Document emailed within 1 workday
Related Documents
Kane, J.M.; Woerner, M.; Weinhold, P.; Wegner, J.; Kinon, B. 1982: A prospective study of tardive dyskinesia development: preliminary results Journal of Clinical Psychopharmacology 2(5): 345-349Sajjad, S.H. 1998: Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses International Clinical Psychopharmacology 13(4): 147-155
Bárány, S.; Ingvast, A.; Gunne, L.M. 1979: Development of acute dystonia and tardive dyskinesia in cebus monkeys Research Communications in Chemical Pathology and Pharmacology 25(2): 269-279
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Staton, R.D.; Brumback, R.A. 1980: Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis) Journal of Clinical Psychiatry 41(12 Part 1): 427-428
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Kennedy, N.J.; Sanborn, J.S. 1992: Disclosure of tardive dyskinesia: effect of written policy on risk disclosure Psychopharmacology Bulletin 28(1): 93-100
Volkov, V.S.; Dragoshanskaia, A.V.; Shur, A.G. 1972: Risk factors for the development of hypertension (findings from observations over a 10 year period) Kardiologiia 12(12): 65-71
Gunne, L.M.; Häggström, J.E. 1985: Experimental tardive dyskinesia Journal of Clinical Psychiatry 46(4 Pt 2): 48-50
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Gardos, G.; Sokol, M.; Cole, J.O.; Sniffin, C. 1976: Eye color and tardive dyskinesia Psychopharmacology Bulletin 12(2): 7 8-7 9
Crane, G.E. 1971: More on amantadine in tardive dyskinesia New England Journal of Medicine 285(20): 1150-1151
Calne, D.B.; Claveria, L.E.; Teychenne, P.F.; Haskayne, L.; Lodge-Patch, I.C. 1974: Pimozide in tardive dyskinesia Transactions of the American Neurological Association 99: 166-170
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Mehta, D.; Eaton, J.; Burch, M.; Mehta, S. 1985: Observations in tardive dyskinesia Journal of Clinical Psychiatry 46(2): 73
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Carta, M.G.; Hardoy, M.C.; Dell'Osso, L.; Carpiniello, B. 2004: Tardive dyskinesia: review of the literature La Clinica Terapeutica 155(4): 127-133
Seeman, M.V.; Patel, J.; Pyke, J. 1981: Tardive dyskinesia with Tourette-like syndrome Journal of Clinical Psychiatry 42(9): 357-358